153 related articles for article (PubMed ID: 33857339)
1. Menopausal hormone therapies and risk of colorectal cancer: a Swedish matched-cohort study.
Liu Q; Simin J; Debelius J; Fall K; Sadr-Azodi O; Engstrand L; Williams C; Brusselaers N
Aliment Pharmacol Ther; 2021 Jun; 53(11):1216-1225. PubMed ID: 33857339
[TBL] [Abstract][Full Text] [Related]
2. Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.
Simin J; Liu Q; Wang X; Fall K; Williams C; Callens S; Engstrand L; Brusselaers N
Acta Oncol; 2021 Jul; 60(7):881-887. PubMed ID: 33861686
[TBL] [Abstract][Full Text] [Related]
3. Menopausal hormone therapy treatment options and ovarian cancer risk: A Swedish prospective population-based matched-cohort study.
Simin J; Tamimi RM; Callens S; Engstrand L; Brusselaers N
Int J Cancer; 2020 Jul; 147(1):33-44. PubMed ID: 31584190
[TBL] [Abstract][Full Text] [Related]
4. Menopausal hormone therapy and cancer risk: An overestimated risk?
Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
[TBL] [Abstract][Full Text] [Related]
5. Menopausal hormone therapy and the risk of esophageal and gastric cancer.
Brusselaers N; Maret-Ouda J; Konings P; El-Serag HB; Lagergren J
Int J Cancer; 2017 Apr; 140(7):1693-1699. PubMed ID: 28006838
[TBL] [Abstract][Full Text] [Related]
6. Association between menopausal hormone therapy use and mortality risk: a Swedish population-based matched cohort study.
Simin J; Khodir H; Fornes R; Tamimi RM; Brusselaers N
Acta Oncol; 2022 May; 61(5):632-640. PubMed ID: 35129052
[TBL] [Abstract][Full Text] [Related]
7. Inverse associations of dietary fiber and menopausal hormone therapy with colorectal cancer risk in the Multiethnic Cohort Study.
Park SY; Wilkens LR; Kolonel LN; Henderson BE; Le Marchand L
Int J Cancer; 2016 Sep; 139(6):1241-50. PubMed ID: 27137137
[TBL] [Abstract][Full Text] [Related]
8. Is breast cancer risk the same for all progestogens?
Stute P
Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
[TBL] [Abstract][Full Text] [Related]
9. The influence of menopausal hormone therapy on tumour characteristics and survival in endometrial cancer patients.
Orgéas CC; Hall P; Wedrén S; Dickman PW; Czene K
Eur J Cancer; 2009 Nov; 45(17):3064-73. PubMed ID: 19493676
[TBL] [Abstract][Full Text] [Related]
10. Menopausal hormone therapy and biliary tract cancer: a population-based matched cohort study in Sweden.
Kilander C; Lagergren J; Konings P; Sadr-Azodi O; Brusselaers N
Acta Oncol; 2019 Mar; 58(3):290-295. PubMed ID: 30656997
[TBL] [Abstract][Full Text] [Related]
11. Menopausal hormone therapy and pancreatic cancer risk in women: a population-based matched cohort study.
Sadr-Azodi O; Konings P; Brusselaers N
United European Gastroenterol J; 2017 Dec; 5(8):1123-1128. PubMed ID: 29238591
[TBL] [Abstract][Full Text] [Related]
12. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
Collaborative Group on Hormonal Factors in Breast Cancer
Lancet; 2019 Sep; 394(10204):1159-1168. PubMed ID: 31474332
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive use and risk of colorectal cancer.
Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
[TBL] [Abstract][Full Text] [Related]
14. Association of menopausal hormone therapy with gastric and colorectal cancer risks in Korean women: A nationwide population-based cohort study.
Baek C; Kim JE; Shin A; Choi JY
Maturitas; 2022 Dec; 166():35-40. PubMed ID: 36055009
[TBL] [Abstract][Full Text] [Related]
15. Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study.
Fornili M; Perduca V; Fournier A; Jérolon A; Boutron-Ruault MC; Maskarinec G; Severi G; Baglietto L
Breast Cancer Res; 2021 Apr; 23(1):47. PubMed ID: 33865453
[TBL] [Abstract][Full Text] [Related]
16. The effect of menopausal hormone therapy on gastrointestinal cancer risk and mortality in South Korea: a population-based cohort study.
Nam JH; Jang SI; Park HS; Kim JH; Lee JK; Lim YJ; Koh MS; Lee JH; Park S; Nam CM; Park EC
BMC Gastroenterol; 2021 Nov; 21(1):440. PubMed ID: 34814853
[TBL] [Abstract][Full Text] [Related]
17. Different menopausal hormone regimens and risk of breast cancer.
Brusselaers N; Tamimi RM; Konings P; Rosner B; Adami HO; Lagergren J
Ann Oncol; 2018 Aug; 29(8):1771-1776. PubMed ID: 29917061
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study.
Cervenka I; Al Rahmoun M; Mahamat-Saleh Y; Savoye I; Boutron-Ruault MC; Fournier A; Kvaskoff M
Int J Cancer; 2019 Oct; 145(7):1754-1767. PubMed ID: 30671928
[TBL] [Abstract][Full Text] [Related]
19. Menopausal hormone therapy and risk of oesophageal adenocarcinoma in a population-based cohort study.
Xie SH; Santoni G; Lagergren J
Br J Cancer; 2022 Jan; 126(1):129-133. PubMed ID: 34671128
[TBL] [Abstract][Full Text] [Related]
20. Menopausal hormone therapy and risk of sarcoidosis: a population-based nested case-control study in Sweden.
Dehara M; Kullberg S; Bixo M; Sachs MC; Grunewald J; Arkema EV
Eur J Epidemiol; 2024 Mar; 39(3):313-322. PubMed ID: 38212490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
